citric acid, anhydrous has been researched along with Carcinoma, Anaplastic in 13 studies
Citric Acid: A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.
citric acid : A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "One of significant characteristics of prostate cancer is slow glycolysis and low FDG avidity." | 2.43 | Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer. ( Liu, Y, 2006) |
| "New colorectal tumors were noted significantly more frequently (P = ." | 1.31 | Measurement of carcinoembryonic antigen in colonic effluent as a high-risk marker for colorectal carcinoma. ( Akedo, I; Iseki, K; Ishiguro, S; Ishikawa, H; Kaji, I; Narahara, H; Otani, T; Suzuki, T; Uedo, N, 2000) |
| "Ten breast carcinomas were immunostained for estrogen and progesterone receptors (ER and PR), Ki-67/ MIB 1, p27/Kip-1, and Bcl-2 after MAR, LTAR with enzymatic pretreatment, or no antigen recovery." | 1.31 | Methods of antigen recovery vary in their usefulness in unmasking specific antigens in immunohistochemistry. ( Frost, AR; Grizzle, WE; Sparks, D, 2000) |
| "Specific activities of follicular adenomas are rather heterogeneous." | 1.27 | Phosphofructokinase in normal thyroid tissue and thyroid neoplasms. ( der Kinderen, PJ; Rijksen, G; Staal, GE; van der Heijden, MC; van Unnik, JA; Verhagen, JN, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (30.77) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, X | 1 |
| Yan, B | 1 |
| Liu, S | 2 |
| Jia, J | 1 |
| Lai, W | 1 |
| Xin, X | 1 |
| Tang, CE | 1 |
| Luo, D | 1 |
| Tan, T | 1 |
| Jiang, Y | 1 |
| Shi, Y | 1 |
| Liu, Y | 2 |
| Xiao, D | 1 |
| Chen, L | 1 |
| Mao, C | 1 |
| Yin, G | 1 |
| Cheng, Y | 1 |
| Fan, J | 1 |
| Cao, Y | 1 |
| Muegge, K | 1 |
| Tao, Y | 1 |
| LUTWAK-MANN, C | 1 |
| Kumar, R | 1 |
| Kumar, M | 1 |
| Jagannathan, NR | 1 |
| Gupta, NP | 1 |
| Hemal, AK | 1 |
| ROTTINO, A | 1 |
| HOFFMANN, GT | 1 |
| BRONDOLO, B | 1 |
| Juang, HH | 1 |
| Shi, SR | 1 |
| Chaiwun, B | 1 |
| Young, L | 1 |
| Cote, RJ | 1 |
| Taylor, CR | 1 |
| Kazumoto, T | 1 |
| Mitsuhashi, N | 1 |
| Hayakawa, K | 1 |
| Yonome, I | 1 |
| Niibe, H | 1 |
| Uedo, N | 1 |
| Ishikawa, H | 1 |
| Narahara, H | 1 |
| Akedo, I | 1 |
| Iseki, K | 1 |
| Kaji, I | 1 |
| Ishiguro, S | 1 |
| Suzuki, T | 1 |
| Otani, T | 1 |
| Frost, AR | 1 |
| Sparks, D | 1 |
| Grizzle, WE | 1 |
| Ward, FT | 1 |
| Anderson, JH | 1 |
| Jelinek, J | 1 |
| Anderson, DW | 1 |
| van der Heijden, MC | 1 |
| Verhagen, JN | 1 |
| Rijksen, G | 1 |
| der Kinderen, PJ | 1 |
| van Unnik, JA | 1 |
| Staal, GE | 1 |
| Nakayama, M | 1 |
| Miyamoto, Y | 1 |
| Hasegawa, R | 1 |
| Kure, F | 1 |
| Saito, A | 1 |
| Kimoto, K | 1 |
| Matsuno, H | 1 |
| Yamashita, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Radiosensitization With a COX-2 Inhibitor (Celecoxib), With Chemoradiation for Cancer of the Head and Neck[NCT00581971] | Phase 1/Phase 2 | 30 participants (Actual) | Interventional | 2002-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Evaluate the response to concurrent celecoxib, carboplatin, paclitaxel, and radiotherapy in the treatment of locally advanced SSC of the head and neck. Response is determined by local control only, local and distant metastasis, distant metastasis only, second primary, and surgical salvage. (NCT00581971)
Timeframe: 2 years from end of treatment (Radiation therapy)
| Intervention | Participants (Number) | ||||
|---|---|---|---|---|---|
| Local Control Only | Local Control and Distant Metastasis | Distant Metastatsis Only | Secondary Primary - Site Unknown | Surgical Salvage | |
| Recurrence | 6 | 2 | 1 | 2 | 3 |
Particpants experiencing Acute Toxicities > Grade 3 (NCT00581971)
Timeframe: 2 years from radiation therapy
| Intervention | participants (Number) | ||
|---|---|---|---|
| Hematologic | Dermatitis | Mucositis/Dysphagia | |
| Acute Toxicity | 12 | 7 | 16 |
1 review available for citric acid, anhydrous and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer.
Topics: Carcinoma; Citric Acid; Dietary Fats; Energy Metabolism; Fatty Acids; Humans; Lipid Metabolism; Male | 2006 |
12 other studies available for citric acid, anhydrous and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Chromatin Remodeling Factor LSH Drives Cancer Progression by Suppressing the Activity of Fumarate Hydratase.
Topics: Animals; Carcinoma; Cell Line, Tumor; Chromatin Assembly and Disassembly; Citric Acid; Citric Acid C | 2016 |
CITRIC ACID IN METASTASIZING CARCINOMA OF THE PROSTATE GLAND.
Topics: Carcinoma; Citrates; Citric Acid; Humans; Male; Metabolism; Neoplasm Metastasis; Neoplasms; Prostati | 1963 |
Proton magnetic resonance spectroscopy with a body coil in the diagnosis of carcinoma prostate.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Choline; Citric Acid; Creatine; Diagnosis, Differential; | 2004 |
Serum citric acid in Hodgkin's disease, lymphoma and carcinoma.
Topics: Carcinoma; Citrates; Citric Acid; Hodgkin Disease; Humans; Lymphoma | 1952 |
Cyclic adenosine 3',5'-monosphosphate mediate prolactin regulation of mitochondrial aconitase in human prostate carcinoma cells.
Topics: Aconitate Hydratase; Carcinoma; Cell Line; Citric Acid; Cyclic AMP; Gene Expression Regulation, Neop | 2004 |
Antigen retrieval technique utilizing citrate buffer or urea solution for immunohistochemical demonstration of androgen receptor in formalin-fixed paraffin sections.
Topics: Antigens, Neoplasm; Buffers; Carcinoma; Citrates; Citric Acid; Frozen Sections; Humans; Immunoenzyme | 1993 |
Radioimmunodetection of lung cancer with IMACIS-1, I-131 labeled monoclonal antibodies to CEA and CA19-9. Comparison of accumulations in irradiated and non-irradiated site.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Aged, 80 and over; Antibodies, Monoclonal; Carcinoma | 1993 |
Measurement of carcinoembryonic antigen in colonic effluent as a high-risk marker for colorectal carcinoma.
Topics: Age Factors; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoembryonic Antigen; Carcinoma; Cathar | 2000 |
Methods of antigen recovery vary in their usefulness in unmasking specific antigens in immunohistochemistry.
Topics: Antigens; Antigens, Nuclear; Breast Neoplasms; Carcinoma; Carcinoma, Ductal, Breast; Cell Cycle Prot | 2000 |
Localization of metastatic adrenal cortical carcinoma with Ga-67.
Topics: Adrenal Cortex Neoplasms; Adult; Carcinoma; Citrates; Citric Acid; Gallium Radioisotopes; Humans; Lu | 1991 |
Phosphofructokinase in normal thyroid tissue and thyroid neoplasms.
Topics: Adenoma; Carcinoma; Citrates; Citric Acid; Humans; Isoenzymes; Kinetics; Phosphofructokinase-1; Thyr | 1986 |
[A case of acinar cell carcinoma of the pancreas with increased uptake of 67Ga citrate].
Topics: Carcinoma; Citrates; Citric Acid; Humans; Male; Middle Aged; Pancreatic Neoplasms; Radionuclide Imag | 1988 |